Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,792 | 93 | 99.2% |
| Education | $13.89 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $309.72 | 17 | $0 (2020) |
| Novo Nordisk Inc | $219.83 | 9 | $0 (2019) |
| Abbott Laboratories | $197.68 | 8 | $0 (2024) |
| Medtronic MiniMed, Inc. | $158.51 | 9 | $0 (2019) |
| Dexcom, Inc. | $107.07 | 6 | $0 (2019) |
| Amgen Inc. | $106.86 | 7 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $84.86 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $82.09 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $68.64 | 4 | $0 (2018) |
| Insulet Corporation | $67.86 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.00 | 8 | Abbott Laboratories ($74.89) |
| 2021 | $13.89 | 1 | Amgen Inc. ($13.89) |
| 2020 | $222.75 | 8 | Abbott Laboratories ($89.93) |
| 2019 | $440.75 | 24 | Dexcom, Inc. ($57.39) |
| 2018 | $442.84 | 24 | AbbVie, Inc. ($114.24) |
| 2017 | $540.36 | 29 | AbbVie, Inc. ($130.98) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes Care | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $10.97 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes Care | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2021 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 02/21/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/10/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/31/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $89.93 | General |
| Category: Diabetes Care | ||||||
| 01/31/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/27/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiology | ||||||
| 01/24/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Diabetes | ||||||
| 01/20/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/06/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Durable Pump | ||||||
| 12/09/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Bone Health | ||||||
| 11/26/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: DIABETES | ||||||
| 10/03/2019 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Endocrinology | ||||||
| 08/26/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,475 | 8,756 | $862,399 | $266,337 |
| 2022 | 14 | 1,324 | 7,715 | $746,176 | $224,048 |
| 2021 | 17 | 1,220 | 5,912 | $650,956 | $196,136 |
| 2020 | 16 | 1,101 | 13,861 | $454,268 | $148,874 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 69 | 6,900 | $342,050 | $125,506 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 602 | 833 | $294,049 | $83,469 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 72 | $35,352 | $10,410 | 29.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 246 | 246 | $57,417 | $10,400 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $32,163 | $9,038 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $21,492 | $6,190 | 28.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 51 | 53 | $18,232 | $5,927 | 32.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 48 | 50 | $18,450 | $5,083 | 27.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 113 | 171 | $16,416 | $4,568 | 27.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 84 | 233 | $16,077 | $2,535 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $4,731 | $1,200 | 25.4% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 26 | 26 | $2,600 | $918.58 | 35.3% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 14 | 16 | $2,560 | $807.50 | 31.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 30 | $810.00 | $285.60 | 35.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 61 | 6,060 | $303,000 | $101,960 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 514 | 722 | $254,866 | $71,197 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 98 | 98 | $44,394 | $12,880 | 29.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 262 | 262 | $38,971 | $8,163 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 53 | $26,023 | $7,657 | 29.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 40 | 45 | $15,480 | $5,406 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $16,716 | $5,275 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 43 | $10,707 | $3,163 | 29.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 75 | 114 | $10,944 | $3,100 | 28.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 76 | 206 | $14,214 | $2,203 | 15.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 11 | 12 | $4,428 | $1,259 | 28.4% |
About Dr. Muhammad Haq, M.D
Dr. Muhammad Haq, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2009. The National Provider Identifier (NPI) number assigned to this provider is 1710126388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Haq, M.D has received a total of $1,806 in payments from pharmaceutical and medical device companies, with $145.00 received in 2024. These payments were reported across 94 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,792).
As a Medicare-enrolled provider, Haq has provided services to 5,120 Medicare beneficiaries, totaling 36,244 services with total Medicare billing of $835,395. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Santa Barbara, CA
- Active Since 02/05/2009
- Last Updated 08/07/2014
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1710126388
Products in Payments
- Minimed 670G System (Device) $142.00
- Ozempic (Drug) $121.24
- Synthroid (Drug) $118.81
- FreeStyle Libre (Device) $108.70
- FREESTYLE LIBRE 3 (Device) $74.89
- Creon (Drug) $70.41
- Victoza (Drug) $68.95
- JARDIANCE (Drug) $68.64
- Omnipod (Device) $67.86
- Androgel (Drug) $58.22
- DEXCOM CGM (Device) $57.39
- AFREZZA (Drug) $55.55
- DISEASE STATE (Drug) $49.82
- TOUJEO (Drug) $46.36
- INVOKANA (Drug) $46.10
- FARXIGA (Drug) $46.04
- Prolia (Biological) $36.23
- BYDUREON (Drug) $36.05
- LEQVIO (Drug) $33.46
- Repatha (Biological) $29.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Santa Barbara
Daniel Berger, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $770,837
Dr. Tricia Westhoff-Pankratz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $121,885
Ashley Thorsell, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $9,526
Kateryna Markova, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,192
Charles Donner, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,082
Mark Wilson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,040